Newly discovered polymorphism associated with prostate cancer risk in African––Americans

By  

Pharmacogenomics, Vol. 8, Iss. 12, 2007-12 ,pp. : 1635-1637

Future Medicine

Access to resources Recommend Favorite

Cathepsin B as a cancer target

By Gondi Christopher S   Rao Jasti S  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 3, 2013-03 ,pp. : 281-291

Informa Healthcare

Access to resources Recommend Favorite

BPH drugs may increase high-grade prostate cancer risk

By  

Reactions Weekly, Vol. 1, Iss. 1394, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Moreira DM, Nickel JC, Gerber L, Muller RL, Andriole GL, Castro-Santamaria R and Freedland SJ. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study. Cancer. 2014;120:190-196.

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4271-4271

Blackwell Publishing

Access to resources Recommend Favorite